The company's stock closed at $14.25 in Friday's trading on Nasdaq. The discovery does not ensure that Agouron will …
La Jolla Pharmaceutical Company is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies to improve outcomes in patients suffering from life-threatening …
La Jolla Pharm (NASDAQ:LJPC) traded in a range yesterday that spanned from a low of $33.10 to a high of $35.47. Yesterday, the shares fell 7.1%, which took the trading range below the 3-day low of $35.50 on volume of 614,000 …
Dec 4 (Reuters) - La Jolla Pharmaceutical Co: * LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES INITIATION …
La Jolla Pharmaceutical Company (OTCQB: LJPC) ("La Jolla"), a leader in the development of therapeutics targeting galectin proteins, announced today that the FDA Office of Orphan Products Development has granted an "Orphan Drug" …